Yahoo Finance10d
Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity
NATICK, Mass., January 21, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today ...
Yahoo Finance6d
Allurion Stock Skyrockets 80% After Hours Following Clinical Study Announcement
Along with a Virtual Care Suite that provide tools for healthcare professionals to monitor and modify treatments, the Allurion Program has a swallowable gastric balloon that calls for no surgical ...
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs
Allurion Technologies shares soared 200% Friday as it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see if the combination improves patients' muscle mass.
Business Wire7d
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced ...